// App-Quantinova.ai

: Immunocompetent 3D Follicular Lymphoma Model: A Preclinical Tool to Design Tailored Immunotherapies

Researchers

Presenter

  • Cèlia Dobaño-López

Principal Investigators

  • Ferran Araujo-Ayala

  • Ferran Nadeu

  • Fabien Gava

  • Carla Faria

  • Marine Norlund

  • Renaud Morin

  • Pascale Bernes-Lasserre

  • Neus Serrat

  • Heribert Playa-Albinyana

  • Andrea Rivero

  • Pablo Mozas

  • Elias Campo

  • Jean-Michel Lagarde

  • Armando Lopez-Guillermo

  • Dolors Colomer

  • Christine Bezombes

  • Patricia Perez-Galan

Medical Centers

  • Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain

  • Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

  • University of Barcelona, Barcelona, Spain

  • IMACTIV-D, Toulouse, France

  • Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain

  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

  • Centre de Recherches en Cancérologie de Toulouse, INSERM, Toulouse, France

Locations

  • Spain

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Non-Hodgkin's Lymphoma

  • Follicular lymphoma

  • Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Lymphomas

Biomarkers

  • Enhancer of zeste homolog 2

  • Programmed cell death protein 1

  • Granzyme B

  • Interferon-gamma

  • Interleukin 10

  • Vascular endothelial growth factor A

  • Interleukin-15

  • Interleukin-2

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Nivolumab

  • Rituximab

  • Interferon Gamma

  • Interleukin-10

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved